By Medpage Today | May 18, 2017
ACC/AHA/HFSA recommend adjusted SPRINT target of <130/80 mm Hg.
Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...
A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...
